ITMI20030317A1 - Terapia combinata comprendente un derivato dell'indolopirrolocarbazolo ed un altro agente antitumorale. - Google Patents

Terapia combinata comprendente un derivato dell'indolopirrolocarbazolo ed un altro agente antitumorale.

Info

Publication number
ITMI20030317A1
ITMI20030317A1 IT000317A ITMI20030317A ITMI20030317A1 IT MI20030317 A1 ITMI20030317 A1 IT MI20030317A1 IT 000317 A IT000317 A IT 000317A IT MI20030317 A ITMI20030317 A IT MI20030317A IT MI20030317 A1 ITMI20030317 A1 IT MI20030317A1
Authority
IT
Italy
Prior art keywords
indolopirrolocarbazolo
derivative
cancer agent
another anti
combined therapy
Prior art date
Application number
IT000317A
Other languages
English (en)
Inventor
Marina Ciomei
Enrico Pesenti
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Priority to IT000317A priority Critical patent/ITMI20030317A1/it
Priority to JP2006502025A priority patent/JP2006518355A/ja
Priority to CA002516097A priority patent/CA2516097A1/en
Priority to PCT/EP2004/050130 priority patent/WO2004073719A1/en
Priority to MXPA05008879A priority patent/MXPA05008879A/es
Priority to EP04711372A priority patent/EP1599210A1/en
Priority to BRPI0407642-7A priority patent/BRPI0407642A/pt
Priority to TW093103888A priority patent/TW200500073A/zh
Priority to CL200400319A priority patent/CL2004000319A1/es
Priority to ARP040100529A priority patent/AR043241A1/es
Publication of ITMI20030317A1 publication Critical patent/ITMI20030317A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Saccharide Compounds (AREA)
IT000317A 2003-02-21 2003-02-21 Terapia combinata comprendente un derivato dell'indolopirrolocarbazolo ed un altro agente antitumorale. ITMI20030317A1 (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT000317A ITMI20030317A1 (it) 2003-02-21 2003-02-21 Terapia combinata comprendente un derivato dell'indolopirrolocarbazolo ed un altro agente antitumorale.
JP2006502025A JP2006518355A (ja) 2003-02-21 2004-02-16 インドロピロロカルバゾール誘導体及び他の抗腫瘍薬を含む併用療法
CA002516097A CA2516097A1 (en) 2003-02-21 2004-02-16 A combined therapy comprising an indolopyrrolocarbazole derivative and another antitumor agent
PCT/EP2004/050130 WO2004073719A1 (en) 2003-02-21 2004-02-16 A combined therapy comprising an indolopyrrolocarbazole derivative and another antitumor agent
MXPA05008879A MXPA05008879A (es) 2003-02-21 2004-02-16 Una terapia combinada que comprende un derivado de indolopirrolocarbazol y otro agente antitumoral.
EP04711372A EP1599210A1 (en) 2003-02-21 2004-02-16 A combined therapy comprising an indolopyrrolocarbazole derivative and another antitumor agent
BRPI0407642-7A BRPI0407642A (pt) 2003-02-21 2004-02-16 terapia combinada compreendendo um derivado indol pirrol carbazol e um outro agente antitumor
TW093103888A TW200500073A (en) 2003-02-21 2004-02-18 Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof
CL200400319A CL2004000319A1 (es) 2003-02-21 2004-02-20 Combinacion farmaceutica que comprende edotecarina o una sal farmaceuticamente aceptable y docetaxel o capacitabina, kit terapeutico, util para el tratamiento del cancer.
ARP040100529A AR043241A1 (es) 2003-02-21 2004-02-20 Terapia combinada que comprende un derivado de indolpirrol-carbazol y otro agente antitumoral

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000317A ITMI20030317A1 (it) 2003-02-21 2003-02-21 Terapia combinata comprendente un derivato dell'indolopirrolocarbazolo ed un altro agente antitumorale.

Publications (1)

Publication Number Publication Date
ITMI20030317A1 true ITMI20030317A1 (it) 2004-08-22

Family

ID=32894164

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000317A ITMI20030317A1 (it) 2003-02-21 2003-02-21 Terapia combinata comprendente un derivato dell'indolopirrolocarbazolo ed un altro agente antitumorale.

Country Status (10)

Country Link
EP (1) EP1599210A1 (it)
JP (1) JP2006518355A (it)
AR (1) AR043241A1 (it)
BR (1) BRPI0407642A (it)
CA (1) CA2516097A1 (it)
CL (1) CL2004000319A1 (it)
IT (1) ITMI20030317A1 (it)
MX (1) MXPA05008879A (it)
TW (1) TW200500073A (it)
WO (1) WO2004073719A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2596801T3 (en) * 2006-10-06 2018-08-13 Bavarian Nordic As RECOMBINANT MODIFIED VACCINIA ANKARA VIRUS CODING A HER-2 ANTIGEN FOR USING CANCER TREATMENT

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441026B1 (en) * 1993-11-08 2002-08-27 Aventis Pharma S.A. Antitumor compositions containing taxane derivatives
EE200200471A (et) * 2000-02-28 2003-12-15 Aventis Pharma S.A. Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini või selle derivaati kombinatsioonis pürimidiini derivaadiga ning on ette nähtud vähktõve raviks

Also Published As

Publication number Publication date
CL2004000319A1 (es) 2005-04-22
JP2006518355A (ja) 2006-08-10
MXPA05008879A (es) 2005-10-05
CA2516097A1 (en) 2004-09-02
WO2004073719A1 (en) 2004-09-02
TW200500073A (en) 2005-01-01
AR043241A1 (es) 2005-07-20
EP1599210A1 (en) 2005-11-30
BRPI0407642A (pt) 2006-03-01

Similar Documents

Publication Publication Date Title
JP2004525194A5 (it)
EE200500035A (et) Personaalne teraapiasektsioon
IL173398A0 (en) Pyridyl derivatives and their use as therapeutic agents
DE60324099D1 (de) Arzneistoffhaltiger tampon
NO20053817D0 (no) Preparater og fremgangsmater for antiviral kombinasjonsterapi.
FR2854158B1 (fr) Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique
FR2866884B1 (fr) Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique
FR2873691B1 (fr) Derives d'amino-piperidine, leur preparation et leur application en therapeutique
FR2864080B1 (fr) Derives de 1-piperazine-et-1-homopiperazine-carboxylates, leur preparation et leur application en therapeutique
FR2854633B1 (fr) Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique
ATE557006T1 (de) 4-hydroxybenzomorphane
FR2843964B1 (fr) Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
FR2850377B1 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
MA27233A1 (fr) Derives de piperazinylacylpiperidine, leur preparation et leur application en therapeutique
FR2873690B1 (fr) Derives d'oxopiperidine, leur preparation et leur application en therapeutique
NL1033403A1 (nl) Therapeutische pyrazolo[3,4-b]pyridinen en indazolen.
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
DK1556382T3 (da) 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
IL164887A0 (en) Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
ZA200210316B (en) Composition and its therapeutic use.
DE60222664D1 (de) Hautbehandlungsmittel
FR2845388B1 (fr) Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
FR2873693B1 (fr) Derives d'amino-tropane, leur preparation et leur application en therapeutique
DE112004001618D2 (de) Pharmazeutischer Wirkstoff gegen Tumorerkrankungen
ITMI20030317A1 (it) Terapia combinata comprendente un derivato dell'indolopirrolocarbazolo ed un altro agente antitumorale.